Comparison of P(2)Y(12) receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registries

AIMS: Among acute coronary syndromes (ACS), ST-segment elevation myocardial infarction (STEMI) has the most severe early clinical course. Recent randomized clinical trials have demonstrated that novel antithrombotic therapies improve in-hospital outcomes in STEMI patients. We aimed to describe the e...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, Leonardo, Zeymer, Uwe, Claeys, Marc J, Dörler, Jakob, Erne, Paul, Matter, Christian M, Radovanovic, Dragana, Weidinger, Franz, Lüscher, Thomas F, Jukema, Johan Wouter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957904/
https://www.ncbi.nlm.nih.gov/pubmed/31965164
http://dx.doi.org/10.1093/ehjcvp/pvaa002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957904/
https://www.ncbi.nlm.nih.gov/pubmed/31965164
http://dx.doi.org/10.1093/ehjcvp/pvaa002

Ejemplares similares